Principal Financial Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-401
Closed -$79K 2505
2020
Q4
$79K Buy
+401
New +$79K ﹤0.01% 2374